Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation

Bibliographic Details
Main Authors: Madlen Jentzsch, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-021-00471-x

Internet

https://doi.org/10.1038/s41408-021-00471-x

Similar Items